Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
cAMP-dependent protein kinase catalytic subunit alpha, beta, or gamma is the catalytic component of the tetrameric holoenzyme protein kinase A (PKA), which mediates most cellular responses to cyclic AMP signaling. PKA catalytic subunits transfer the gamma-phosphoryl group from ATP to serine or threonine residues on target proteins, altering their function. Each isoform (alpha, beta, gamma) is encoded by a distinct gene (PRKACA, PRKACB, PRKACG, respectively) and displays some tissue-specific expression. Activation occurs when cAMP binds to PKA regulatory subunits, releasing active catalytic subunits. Through its diverse substrate profile, PKA influences metabolism, transcription, cell cycle, growth, and survival, and dysregulation has been implicated in diseases such as cancer and endocrine disorders.
Phosphorylation of serine/threonine residues on substrate proteins in response to cAMP second messenger signaling cascade
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cAMP-dependent protein kinase catalytic subunit alpha (PRKACA), beta (PRKACB), or gamma (PRKACG) (PKA catalytic subunit (commonly PRKACA, PRKACB, PRKACG for specific isoforms)).